Valuation: McKesson Corporation

Capitalization 91.42B 78.67B 71.93B 68.63B 126B 8,771B 128B 863B 334B 4,164B 343B 336B 14,507B P/E ratio 2027 *
18x
P/E ratio 2028 * 15.9x
Enterprise value 96.22B 82.8B 75.71B 72.23B 132B 9,232B 135B 908B 351B 4,382B 361B 353B 15,268B EV / Sales 2027 *
0.22x
EV / Sales 2028 * 0.21x
Free-Float
42.88%
Yield 2027 *
0.44%
Yield 2028 * 0.47%
1 day+1.79%
1 week+3.33%
Current month-6.70%
1 month-11.91%
3 months-18.63%
6 months-9.68%
Current year-7.28%
1 week 723.68
Extreme 723.68
766.43
1 month 723.68
Extreme 723.68
873.03
Current year 723.68
Extreme 723.68
999
1 year 637
Extreme 637
999
3 years 373.28
Extreme 373.28
999
5 years 184.43
Extreme 184.43
999
10 years 106.11
Extreme 106.11
999
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2019
Director of Finance/CFO 57 01/01/2018
Chief Tech/Sci/R&D Officer 53 03/10/2023
Director TitleAgeSince
Chairman 75 01/04/2022
Director/Board Member 70 24/04/2018
Chairman 59 01/05/2026
Change 5d. change 1-year change 3-years change Capi.($)
+1.79%+3.33%+7.61%+94.44% 91.42B
+0.42%+6.29%+28.46%+128.79% 45.72B
0.00%+0.35%-3.70%+308.57% 23.52B
-4.57%-5.89%-20.34%-24.18% 8.07B
-0.95%-1.99%-8.38%-23.26% 8.25B
-1.43%-2.98%-2.93%-33.03% 7.13B
-0.43%-3.90%+20.99%+10.58% 6.21B
+0.55%-0.30%-3.68%+8.14% 5.22B
-0.80%-1.98%-4.62%-14.56% 3.63B
+2.78%+1.33%+22.87%+30.25% 3.62B
Average -0.26%-0.54%+3.63%+48.57% 20.28B
Weighted average by Cap. +0.67%+2.40%+9.04%+105.14%

Financials

2027 *2028 *
Net sales 432B 371B 340B 324B 594B 41,413B 604B 4,074B 1,577B 19,659B 1,620B 1,585B 68,491B 464B 399B 365B 348B 638B 44,511B 649B 4,379B 1,695B 21,130B 1,741B 1,704B 73,616B
Net income 4.93B 4.24B 3.88B 3.7B 6.78B 473B 6.89B 46.49B 17.99B 224B 18.48B 18.09B 782B 5.42B 4.67B 4.27B 4.07B 7.46B 520B 7.59B 51.2B 19.81B 247B 20.35B 19.92B 861B
Net Debt 4.8B 4.13B 3.78B 3.6B 6.61B 461B 6.72B 45.31B 17.53B 219B 18.01B 17.63B 762B 4.55B 3.91B 3.58B 3.41B 6.26B 436B 6.36B 42.92B 16.61B 207B 17.06B 16.7B 722B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
42,300
Date Price Change Volume
15/05/26 760.57 $ +1.79% 1,534,439
14/05/26 747.23 $ +1.36% 933,576
13/05/26 737.18 $ +0.34% 966,010
12/05/26 734.69 $ +1.31% 951,694
11/05/26 725.17 $ -1.48% 1,693,267
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
760.57USD
Average target price
949.73USD
Spread / Average Target
+24.87%

Quarterly revenue - Rate of surprise